Research output per year
Research output per year
Personal profile
Research Interests
Dr. Woodahl’s research focuses on precision medicine and pharmacogenomics to identify sources of interindividual variability in disease treatment and prevention. Translation of pharmacogenomics into clinical practice requires genetic research with diverse patient populations to accurately predict drug response and toxicity for all people regardless of geographic location, ethnicity, or age. We use community-based participatory research to address complex and important challenges to conducting precision medicine research and aid in the translation of precision medicine research into the clinic.
- Precision Medicine
- Pharmacogenomics/Pharmacogenetics
- Health Humanities
- Health Equity
- Rural and Tribal Populations
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Bachelor, Biochemistry, University of Notre Dame
PhD, Pharmaceutics, University of Washington
Fingerprint
Dive into the research topics where Erica Woodahl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific Activity
Zhao, F., Atxabal, U., Mariottini, S., Yi, F., Lotti, J. S., Layeux, M. S., Currier, C., Maderia, M. P., Cornelison, L. E., Anderson, C. M., Schultz, E. P., Zhang, Z., Jiang, L., Gao, Z., Liu, N., Woodahl, E. L., Bunch, L., Hansen, K. B. & Clausen, R. P., Feb 13 2025, In: Journal of Medicinal Chemistry. 68, 3, p. 3572-3590 19 p.Research output: Contribution to journal › Article › peer-review
-
Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science
Walley, A. H., Dupuis, L. N., Woodahl, E. L. & Killam, S. R., Sep 2025, In: Clinical and Translational Science. 18, 9, e70362.Research output: Contribution to journal › Short survey › peer-review
Open Access -
Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community
Wichman, M. L., Wall, D. M., Garcia Mota, S. S., Killam, S. R., Brown, K. E., Aagaard, K., Swaney, J., Muzquiz, L. A. I., Corum, B. N., Claw, K. G. & Woodahl, E. L., Mar 2025, In: Clinical and Translational Science. 18, 3, p. e70194 e70194.Research output: Contribution to journal › Article › peer-review
Open Access -
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges
the Pharmacogenomics Global Research Network (PGRN) Publications Committee, Oct 2025, In: Clinical Pharmacology and Therapeutics. 118, 4, p. 778-789 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation
Cavallari, L. H., Hicks, J. K., Patel, J. N., Elchynski, A. L., Smith, D. M., Bargal, S. A., Fleck, A., Aquilante, C. L., Killam, S. R., Lemke, L., Ochi, T., Ramsey, L. B., Haidar, C. E., Ho, T., El Rouby, N., Monte, A. A., Allen, J. D., Beitelshees, A. L., Bishop, J. R. & Bousman, C. & 28 others, , Jan 2025, In: Pharmacogenetics and Genomics. 35, 1, p. 1-11 11 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations